QTRX250117P27500
- 0.00
- 0.000.00%
Quanterix Newsroom
TD Cowen Reaffirms Their Hold Rating on Quanterix (QTRX)
US stocks are moving | Announced a full stock merger agreement with Quanterix (QTRX.US), Akoya Biosciences (AKYA.US) surged over 16%.
As of the time of writing, the stock has risen more than 16%, priced at $3.09.
Shareholder Alert: Ademi LLP Investigates Whether Akoya Biosciences, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Express News | Quanterix Down 15.2%
Traders Digest Strong Jobs Growth as US Equity Futures Drop Pre-Bell
Express News | Akoya Biosciences Inc - Quanterix to Pay $9 Million Termination Fee if Merger Terminated-SEC Filing
Quanterix To Buy Akoya Biosciences In All Stock Deal; QTRX Up In Pre-Market
Express News | Akoya Biosciences Shares Extend Gains, Last up 51.2% Premarket
Akoya Climbs After Merger Deal With Quanterix
Quanterix: Combined Co Will Continue to Operate Under Quanterix Name >QTRX
Quanterix: Masoud Toloue Will Serve as CEO >QTRX
Quanterix: Transaction Expected to Close in 2Q of 2025 >QTRX
Quanterix Shareholders to Own About 70% of Combined Co >QTRX
Express News | Quanterix Corp - Expected $40 Million Annual Cost Synergies by End of 2026
Express News | Quanterix Corp - Akoya Shareholders to Receive 0.318 Shares of Quanterix Stock per Share
Press Release: Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
Express News | Quanterix Is Close to All-Stock Deal for Akoya Bioscience - Bloomberg News
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
Scotiabank Maintains Quanterix(QTRX.US) With Buy Rating, Maintains Target Price $28
David R. Walt Receives National Medal of Technology and Innovation